Skip to main content
Premium Trial:

Request an Annual Quote

XDx to Use Ingenuity Software to Better Understand Gene Expression Tied to Immunity

NEW YORK (GenomeWeb News) — XDx, a molecular diagnostics company specializing in the immune system, has licensed Ingenuity Systems’ software, Ingenuity said today.
 
The IPA 5.0 software is used to “model, analyze, and understand” biological and chemical systems, Ingenuity said.
 
XDx measures gene expression in patient blood to monitor the immune system. Ingenuity said the IPA 5.0 enables users to “apply filters to their data to determine whether a particular gene or protein is detectable in sentinel tissues or other bodily fluids. ...."
 
Tod Klingler, vice president of Informatics at XDx, said in a statement that the software “provides us with access to its extensive knowledge base of gene function information assembled from the scientific literature through easy-to-use tools that our researchers can use to rapidly evaluate candidate biomarkers. Specifically, IPA allows us to make sense of our gene expression data in the context of known immune system interactions and pathways."
 
Financial terms of the agreement were not released.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.